when is retatrutide expected to be available Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide: What It Is &

Wegovy is licensed in the UK in doses up to 2.4mg for weight loss and, on 14 September 2025, Novo Nordisk published results of a phase IIIb clinical trial (STEP UP, NCT05646706) of a 7.2mg dose of semaglutide for subcutaneous injection 1

Understanding this process more clearly could help researchers design the next generation of GLP-1-based treatments that are even more precise and effective, first author Sam Van de Velde told BioWorld

Thus, treatment of LNCaP cells with the DNA demethylating agent 5-azacytidine also restored activating histone modifications on GSTP1 and as a result reactivated transcription

Medical patients may access Ipamorelin under physician-monitored peptide therapy through licensed HRT clinics

Selenium supports the enzymes that allow the thyroid to function efficiently, which in turn helps regulate mood, energy, and cycle timing

He wrote that he knew several people who had been bitten by Gila monsters but had not died from the bite